Study of RP2 Monotherapy and RP2 in Combination With Nivolumab in Patients With Solid Tumors
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Cancer
Interventions: BIOLOGICAL: RP2|BIOLOGICAL: nivolumab
Sponsor: Replimune Inc.